stockrowRadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.
- Revenue
- +25.0%
- EPS
- −47.4%
- Free cash flow
- −43.2%
- Total debt
- +21.2%
Quarter to June 2026, against a year earlier
Follow RDNT
Alert me
RadNet, Inc. (RDNT) Debt to equity
RadNet, Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.9×, up 0.1× from fiscal 2025 (0.8×). Over the past ten years it has ranged from 0.8× (fiscal 2025) to 16.6× (fiscal 2015) — the current reading is the lowest in ten years. That is above the Diagnostics & Research industry median of 0.0× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.8× | (10.35%) |
| FY2024 | 0.9× | (10.20%) |
| FY2023 | 1.0× | (46.04%) |
| FY2022 | 1.9× | (21.94%) |
| FY2021 | 2.4× | (15.16%) |
| FY2020 | 2.8× | (14.29%) |
| FY2019 | 3.3× | (2.86%) |
| FY2018 | 3.4× | (61.47%) |
| FY2017 | 8.7× | (29.07%) |
| FY2016 | 12.3× | (26.16%) |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Jun 2026 | 0.9× | 19.11% |
| Mar 2026 | 0.8× | (2.14%) |
| Dec 2025 | 0.8× | (1.37%) |
| Sep 2025 | 0.8× | (10.78%) |
| 42 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| VCYT Veracyte, Inc. compare | 0.0× |
| CDNA CareDx, Inc. compare | 0.0× |
| GRAL GRAIL, Inc. compare | 0.0× |
| BLLN BillionToOne, Inc. compare | 0.0× |
| ADPT Adaptive Biotechnologies Corporation compare | 0.0× |
| ICLR ICON PLC compare | 0.4× |
| QGEN QIAGEN N.V. compare | 0.5× |
| RDNT RadNet, Inc. | 0.9× |
| SHC Sotera Health Company compare | 3.1× |
| Diagnostics & Research industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on RDNT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement